CA2385854A1 - Formulation for menopausal women - Google Patents

Formulation for menopausal women Download PDF

Info

Publication number
CA2385854A1
CA2385854A1 CA002385854A CA2385854A CA2385854A1 CA 2385854 A1 CA2385854 A1 CA 2385854A1 CA 002385854 A CA002385854 A CA 002385854A CA 2385854 A CA2385854 A CA 2385854A CA 2385854 A1 CA2385854 A1 CA 2385854A1
Authority
CA
Canada
Prior art keywords
menopausal women
formulation
premenopausal
menopause
relief
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002385854A
Other languages
French (fr)
Other versions
CA2385854C (en
Inventor
R. Saul Levinson
Marc S. Hermelin
Mitchell I. Kirschner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amag Pharma USA Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002492417A priority Critical patent/CA2492417C/en
Publication of CA2385854A1 publication Critical patent/CA2385854A1/en
Application granted granted Critical
Publication of CA2385854C publication Critical patent/CA2385854C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.
CA002385854A 1999-09-30 2000-08-28 Formulation for menopausal women Expired - Fee Related CA2385854C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002492417A CA2492417C (en) 1999-09-30 2000-08-28 Formulation for menopausal women

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/409,059 1999-09-30
US09/409,059 US6479545B1 (en) 1999-09-30 1999-09-30 Formulation for menopausal women
PCT/US2000/023527 WO2001024772A1 (en) 1999-09-30 2000-08-28 Formulation for menopausal women

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002492417A Division CA2492417C (en) 1999-09-30 2000-08-28 Formulation for menopausal women

Publications (2)

Publication Number Publication Date
CA2385854A1 true CA2385854A1 (en) 2001-04-12
CA2385854C CA2385854C (en) 2005-04-12

Family

ID=23618887

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002645397A Abandoned CA2645397A1 (en) 1999-09-30 2000-08-28 Formulation for menopausal women
CA002385854A Expired - Fee Related CA2385854C (en) 1999-09-30 2000-08-28 Formulation for menopausal women

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002645397A Abandoned CA2645397A1 (en) 1999-09-30 2000-08-28 Formulation for menopausal women

Country Status (14)

Country Link
US (5) US6479545B1 (en)
EP (1) EP1216024B1 (en)
JP (1) JP2003510344A (en)
KR (1) KR100831511B1 (en)
CN (1) CN1391464A (en)
AT (1) ATE357213T1 (en)
AU (1) AU778507B2 (en)
BR (1) BR0014438A (en)
CA (2) CA2645397A1 (en)
DE (2) DE00957857T1 (en)
ES (1) ES2195798T3 (en)
MX (1) MXPA02003101A (en)
WO (1) WO2001024772A1 (en)
ZA (1) ZA200202633B (en)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012623A1 (en) * 1995-10-06 1997-04-10 Arch Development Corporation Methods and compositions for viral enhancement of cell killing
EP1175158A1 (en) * 1999-05-07 2002-01-30 Trustees Of Tufts College Immune stimulating dietary supplement and methods of use thereof
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
AU2002219949A1 (en) * 2000-11-29 2002-06-11 Smith Kline Beecham Corporation Dietary composition containing conjugated linoleic acid and calcium for improved health
MXPA03008367A (en) * 2001-03-16 2004-11-12 Wyeth Corp Hormone replacement therapy.
AT411327B (en) * 2001-08-23 2003-12-29 Heil Bettina Fast absorption rectal suppository for treating hormone deficiency, comprises progesterone or its precursor dehydroepiandrosterone and unsaturated, unesterified fatty acid(s)
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
US6911438B2 (en) * 2001-09-12 2005-06-28 Jonathan V. Wright Hormone replacement formulation
NL1019368C2 (en) 2001-11-14 2003-05-20 Nutricia Nv Preparation for improving receptor performance.
US6821532B2 (en) * 2001-11-16 2004-11-23 Unitel Technologies, Inc. Methods and compositions for the treatment of benign prostatic hypertrophy
AU2002343249B2 (en) * 2002-02-21 2009-02-05 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin B12
WO2003082339A1 (en) * 2002-03-22 2003-10-09 Doc's Guide, Inc. Multivitamin and mineral nutritional supplement
US6610331B1 (en) * 2002-05-30 2003-08-26 Scott M. Sweazy Fertility kit
AU2003247685A1 (en) * 2002-07-02 2004-01-23 Galileo Pharmaceuticals, Inc. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
AU2003261147A1 (en) * 2002-07-12 2004-02-02 University Of Rochester Use of amino acids for treatment of various conditions
NZ569868A (en) 2002-09-27 2010-01-29 Martek Biosciences Corp Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
US20050064013A1 (en) * 2002-10-11 2005-03-24 Jeffrey Liebrech Ready to drink beverage composition having liquid form HGH pre-cursor and method of making same
GB0228571D0 (en) * 2002-12-06 2003-01-15 Novartis Ag Organic compounds
TWI322691B (en) 2003-04-11 2010-04-01 Follicle-stimulating hormone reducing agent
US20040253319A1 (en) * 2003-06-11 2004-12-16 Shrirang Netke Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US7857913B2 (en) * 2003-06-26 2010-12-28 Spindler William E Cleaning compound for cleaning surfaces in a food processing environment
US20050032740A1 (en) * 2003-08-06 2005-02-10 Balaji Venkataraman Vitamin compositions for the treatment and prevention of vascular disease and dementia
US20050032741A1 (en) * 2003-08-06 2005-02-10 Balaji Venkataraman Vitamin Compositions
JP2005075804A (en) * 2003-09-03 2005-03-24 Toyo Capsule Kk Medicinal composition including menatetrenone
US7875291B1 (en) 2003-09-05 2011-01-25 Glu-Pro, Inc. Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
BRPI0414500A (en) * 2003-09-19 2006-11-07 Drugtech Corp pharmaceutical formulation composition to treat a vaginal infection, and methods to treat a vaginal infection, to stabilize a clindamycin formulation, to treat or prevent a recurrence of a vaginal infection in a patient and to treat vaginal conditions
US20050112215A1 (en) * 2003-10-09 2005-05-26 Valerie Otto Cramp bark extract and method of extraction
US20050158404A1 (en) * 2003-11-18 2005-07-21 Goodless Dean R. Composition and method for treatment of acne
US20050202038A1 (en) * 2004-03-10 2005-09-15 Green Roger E. Composition and method for minimizing residual fecal matter in the perianal area
US7265101B2 (en) * 2004-04-07 2007-09-04 Rutgers, The State University Of New Jersey Appetite-suppressing compositions and methods
GB2414181A (en) * 2004-05-19 2005-11-23 Merck & Co Inc compositions containing a bisphosphonate and a Vitamin D derivative
US20050266130A1 (en) * 2004-05-28 2005-12-01 Henry Aoki Method for solidification and storing of components extracted from plant, animal, or mineral matter and extract components extracted from held plant, animal, or mineral matter
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
MX2007013631A (en) * 2005-05-09 2008-01-24 Drugtech Corp Modified-release pharmaceutical compositions.
UY29527A1 (en) 2005-05-13 2006-12-29 Schering Ag PHARMACCUTIC COMPOSITION CONTAINING GESTRGENS AND / OR ESTRNGENS AND 5-METHYL - (6S) - TETRHYDROPHOLATE.
JP2007023010A (en) * 2005-07-19 2007-02-01 Toshiro Azegami Oral composition for adjusting hormone balance after menopause and for preventing and improving parkinson disease
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US20070048367A1 (en) * 2005-08-31 2007-03-01 Mom Enterprises, Inc. Herbal composition for treating morning sickness
WO2007073525A2 (en) * 2005-11-28 2007-06-28 Yvonne Daily Hot-flash wipes and clothing
US20070154516A1 (en) * 2006-01-05 2007-07-05 Drugtech Corporation Drug delivery system
US20070224226A1 (en) * 2006-01-05 2007-09-27 Drugtech Corporation Composition and method of use thereof
MX2008009177A (en) * 2006-01-20 2008-12-05 Pear Tree Pharmaceuticals Inc Method of treating atrophic vaginitis.
JP5193196B2 (en) 2006-06-02 2013-05-08 ペア ツリー ウーマンズ ヘルス ケア Methods of treatment for atrophic vaginitis
US20080057144A1 (en) * 2006-09-01 2008-03-06 Cathy Beggan Wake up on time dietary supplement and method of use
WO2008073779A2 (en) * 2006-12-07 2008-06-19 Drugtech Corporation Compositions and methods for treating seizures
US20130115320A1 (en) 2007-03-30 2013-05-09 Dynova Laboratories, Inc. Therapeutic agent for intranasal administration and method of making and using same
US20080241290A1 (en) * 2007-03-30 2008-10-02 Wayne Jeffrey Perry Sinus relief composition and method of producing the same
US20080242741A1 (en) * 2007-03-30 2008-10-02 Wayne Jeffrey Perry Intranasal drug delivery system
WO2008123970A1 (en) * 2007-04-02 2008-10-16 Alfredo Avila Herbal formulation for the treatment of bone fractures and osseous defects
US20090053319A1 (en) * 2007-08-21 2009-02-26 Wayne Jeffrey Perry Sore Throat Relief Composition And Method of Producing Same
US20090069446A1 (en) * 2007-09-06 2009-03-12 Wayne Jeffrey Perry Dendritic salt therapeutic agent delivery system
CA2639512A1 (en) * 2007-09-10 2009-03-10 Sicap Industries, Llc Nasal rinse additive
US9125844B1 (en) 2007-09-25 2015-09-08 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
US7964189B1 (en) 2007-09-25 2011-06-21 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
UY31410A1 (en) * 2007-10-30 2009-05-29 COMPOSITION THAT INCLUDES POLYINSATURATED FATTY ACIDS AND ACTIVATED VEGETABLE CARBON
US7824716B1 (en) * 2008-04-11 2010-11-02 Van De Pol Sylvia Herbal women's health formula
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US8535660B1 (en) 2008-05-27 2013-09-17 Argent Development Group, Llc Nutritional supplements for pregnant women
US8535659B1 (en) 2008-05-27 2013-09-17 Argent Development Group, Llc Nutritional supplements for pregnant women
US20100040708A1 (en) * 2008-08-13 2010-02-18 Vicki Boynton Herbal composition
WO2010107505A1 (en) * 2009-03-20 2010-09-23 Milk Specialties Company Non-settling galacto-oligosaccharide-rich liquid concentrate and related methods and nutritional compositions
IT1397405B1 (en) * 2009-06-23 2013-01-10 A M S A S R L SUPPLEMENTARY FORMULATION AIMED AT THE CHECK OF THE RECURRENT MULTIFACTORIAL ORGANIC ALTERATIONS IN THE MENOPAUSE PERIOD
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3078375B1 (en) * 2013-10-09 2021-05-12 Ajinomoto Co., Inc. Anti-fatigue composition
KR101400913B1 (en) * 2014-03-12 2014-05-28 주식회사 파미니티 Pharmaceutical composition and food composition for preventing, treating or improving woman hormone controlling disorder
KR20170005819A (en) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 Natural combination hormone replacement formulations and therapies
US9392814B2 (en) * 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
CN104027339B (en) * 2014-06-12 2017-01-18 王淑芳 Vitamin composition and application thereof in regulating ovarian function
JP2017523138A (en) 2014-07-29 2017-08-17 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． Transdermal cream
MY190110A (en) * 2015-01-14 2022-03-29 Pf Consumer Healthcare 1 Llc Oral delivery product
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CN105944088A (en) * 2016-06-29 2016-09-21 中国人民解放军第三军医大学第附属医院 Composition for regulating ovarian function and application of composition
US10357529B2 (en) * 2016-11-07 2019-07-23 Rvrs, Llc Natural formulation for treating hangover
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US471387A (en) * 1892-03-22 Photographic album
NL8403433A (en) * 1984-11-09 1986-06-02 Holland Melkunie FOOD SUPPLY PREPARATION BASED ON MILK COMPONENTS.
GB8524276D0 (en) 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
US4752479A (en) 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
GB8621816D0 (en) 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
US4851431A (en) 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition
US4900734A (en) 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
EP0658629A1 (en) 1987-10-14 1995-06-21 Kao Corporation Process for preparation of polyol fatty acid ester and glyceride mixture obtained
IL91802A (en) 1988-10-27 1994-05-30 Univ Bar Ilan Compositions containing linolenic acid derivativesfor treating Alzheimer's disease, related dementias and epilepsy
US5012761A (en) * 1988-11-17 1991-05-07 Oh Suk Y Chicken egg having relatively high percentage of long chain fatty acids and method of reducing heart related disease in humans using such eggs
US4945103A (en) 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
US5514392A (en) * 1989-08-30 1996-05-07 Seawell Corporation N.V. Packaging for perishable goods
GB9112052D0 (en) 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
US5670201A (en) 1991-06-21 1997-09-23 Snow Brand Milk Co., Ltd. Low allergenic nutrient composition and method of using same
US5087586A (en) * 1991-07-03 1992-02-11 Micron Technology, Inc. Process for creating fully-recessed field isolation regions by oxidizing a selectively-grown epitaxial silicon layer
US5223285A (en) 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
GB9211229D0 (en) 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
GB9217780D0 (en) 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
WO1994006415A1 (en) 1992-09-23 1994-03-31 Kv Pharmaceutical Corporation Multi-vitamin and mineral supplement for pregnant women
EP0675725B1 (en) 1992-12-23 2002-01-30 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5576666A (en) 1993-11-12 1996-11-19 Nippondenso Technical Center Usa, Inc. Fractional-N frequency synthesizer with temperature compensation
US5484623A (en) 1994-01-10 1996-01-16 Mclean; Linsey Dietary system high in oil intake for the treatment of obesity and for the lowering of saturated fats
US5855949A (en) * 1994-01-10 1999-01-05 Mclean; Linsey Dietary system high in oil intake
US5869084A (en) 1994-06-20 1999-02-09 K-V Pharmaceuticals Co. Multi-vitamin and mineral supplements for women
EP0707850A1 (en) * 1994-09-21 1996-04-24 Scotia Holdings Plc Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain
US5514382A (en) 1994-10-17 1996-05-07 Sultenfuss; Sherry Daily vitamin and mineral supplement for women
US5589468A (en) 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5514328A (en) 1995-05-12 1996-05-07 Stoody Deloro Stellite, Inc. Cavitation erosion resistent steel
GB9510636D0 (en) 1995-05-25 1995-07-19 Scotia Holdings Plc Fatty acid treatment
AU722050B2 (en) * 1996-01-31 2000-07-20 South Alabama Medical Science Foundation Food and vitamin preparations containing the natural isomer of reduced folates
US5807586A (en) 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
AU718218B2 (en) * 1996-07-30 2000-04-13 Energetics Inc. Dietary supplements
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
US5922704A (en) * 1997-12-24 1999-07-13 Feeling Fine Company Llc Optimal nutritional supplement for men
US6048846A (en) 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
WO1999065337A1 (en) 1998-06-19 1999-12-23 Beth Israel Deaconess Medical Center Dietary supplement for post-menopausal women
US6569857B1 (en) 1999-05-03 2003-05-27 Drugtech Corporation Dietary supplement
US6258846B1 (en) 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
US6479545B1 (en) 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
JP2008056612A (en) 2006-08-31 2008-03-13 Koei Chem Co Ltd Process for preparing aminopyridines

Also Published As

Publication number Publication date
EP1216024B1 (en) 2007-03-21
ATE357213T1 (en) 2007-04-15
KR100831511B1 (en) 2008-05-22
DE00957857T1 (en) 2005-03-31
AU778507B2 (en) 2004-12-09
WO2001024772A1 (en) 2001-04-12
EP1216024A1 (en) 2002-06-26
KR20020048424A (en) 2002-06-22
BR0014438A (en) 2002-08-20
US20020173510A1 (en) 2002-11-21
AU6941600A (en) 2001-05-10
DE60034046D1 (en) 2007-05-03
US6479545B1 (en) 2002-11-12
JP2003510344A (en) 2003-03-18
ES2195798T3 (en) 2007-11-16
US20050106266A1 (en) 2005-05-19
CA2385854C (en) 2005-04-12
US20020137749A1 (en) 2002-09-26
ES2195798T1 (en) 2003-12-16
US7687485B2 (en) 2010-03-30
CN1391464A (en) 2003-01-15
CA2645397A1 (en) 2001-04-12
ZA200202633B (en) 2003-04-30
MXPA02003101A (en) 2003-08-20
DE60034046T2 (en) 2007-12-06
US20090068289A1 (en) 2009-03-12
EP1216024A4 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
CA2385854A1 (en) Formulation for menopausal women
CA2092199A1 (en) Stretchable absorbent articles
EP1025850A4 (en) Isoflavone-containing compositions
WO2001017973A3 (en) Novel herbicides
WO2004069152A3 (en) Δ4,5 glycuronidase and uses thereof
AU9744298A (en) Substituted tetrahydronaphthaline and analogous compounds
AUPQ485999A0 (en) P. gingivalis antigenic composition
CA2198195A1 (en) Container with freeze-dried vaccine components
CA2179132A1 (en) Fitting for an appliance such as a sink
CA2327784A1 (en) Triazolones with a neuroprotective action
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
CA2372720A1 (en) Androgen glycosides and androgenic activity thereof
WO2001009122A3 (en) Serotonergic benzofurans
AU4925200A (en) Oral composition containing perlite
CA2263846A1 (en) Novel pyranoside derivatives
CA2492417A1 (en) Formulation for menopausal women
AU2001274422A1 (en) Compositions based on aminoacids, suitable for improving muscle performance
CA2319010A1 (en) Pharmaceutical compositions
CA2372664A1 (en) Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa
WO1999048851A3 (en) Processes for preparing intermediates
BG103175A (en) Water soluble compound and cellulose-containing granulates
CA2255980A1 (en) Non-temper, low lauric fat compositions
WO2002098438A1 (en) Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
EP1123695A3 (en) Oral composition comprising capsules containing keratin
CA2299503A1 (en) Anti-first-pass effect compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed